Lymphoma Nonhodgkin
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) (NCT04618081) | Celgene | 2020-12-17 |
| Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006) (NCT03483103) | Juno Therapeutics, a Subsidiary of Celgene | 2018-07-27 |
| A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL (NCT03971305) | Sun Yat-sen University | 2017-05-05 |
Track Lymphoma Nonhodgkin automatically
Every clearance here is in the API, with alerts when new ones post.